CS
Cellectis SA
🇺🇸XNAS.CLLSUnited StatesHealthcare
$3.86USDup +0.25 (+6.93%)ClosedDelayed9:46 PM
Price$3.86+0.25 (+6.93%)
Profile
- Healthcare
- Biotechnology
- United States
Identity
- Exchange
- Nasdaq . XNAS
- Type
- Stock
- ISIN
- US15117K1034
- CUSIP
- 15117K103
Company
- Employees
- 224
- Headquarters
- Paris, United States
- Website
- https://www.cellectis.com
- CEO
- Dr. David J. Sourdive Ph.D.
Market
- Shares outstanding
- 72.7M
- Market cap
- $280.2M
Key dates
- Next earnings
- Nov 6, 2026
Highlights
- Market cap
- $280.2M
- EPS LTM
- -$0.90calculatedCalculated by Finzer, not reported by the data provider.
- P/E LTM
- -4.30calculatedCalculated by Finzer, not reported by the data provider.
- Div yield
- 0%calculatedCalculated by Finzer, not reported by the data provider.
Fundamentals (LTM)
- Revenue
- $56.59M+0.52%up year on year
- Net income
- -$65.35M-10.76%down year on year
- Gross margin
- 74.71%-9.65%down year on year
- Free cash flow
- -$44.06M-20.41%down year on year
Other listings
- XPAR.ALCLSEuronext Paris
- XSTU.ZVAAStuttgart Stock Exchange
- XFRA.ZVAFrankfurt Stock Exchange
- XFRA.ZVAAFrankfurt Stock Exchange
These are the venues Finzer covers, not every venue that exists.
Business summary
No company summary reported yet.